This Is a Neuron on Nicotine

When a person takes a puff on a cigarette, nicotine floods into the brain, latching onto receptors on the surface of neurons and producing feelings of happiness. But nicotine does not simply stay on the surface of cells - the drug actually permeates into neural cells and alters them from the inside out. Now, a team of scientists has developed a protein sensor that glows in the presence of nicotine, allowing the researchers to observe nicotine's movements in cells and reveal more about the nature of nicotine addiction.

The work was led by Henry Lester, professor of biology at Caltech and previously a visiting scientist at the Janelia Research Campus of the Howard Hughes Medical Institute (HHMI). A paper describing the research appears online on February 4 in the Journal of General Physiology. Lester is also an affiliated faculty member of the Tianqiao and Chrissy Chen Institute for Neuroscience at Caltech.

The endoplasmic reticulum is the equivalent of a cell's factory and warehouse--the place where proteins are synthesized and packaged in order to be shipped to various other locations both inside and outside of the cell. Nicotinic receptors (nAChRs) are among these proteins; after being manufactured in the endoplasmic reticulum, they then travel to the cell's surface. When nicotine molecules enter the body, they travel through the bloodstream and reach brain cells, where they meet the nAChRs on the surface of these cells. This triggers the cells' processes of releasing chemicals of reward and happiness.

What happens once nicotine has moved into the cells, however, has not been well understood. Lester and others previously found that some nAChRs remain in the "warehouse"--the endoplasmic reticulum--where they, too, can bind to nicotine. Hoping to gain insights into nicotine's effects within cells, Lester and his team developed a tool called a biosensor to visualize where the drug collects inside of cells. The biosensor is composed of a special protein that can open and close, like a Venus flytrap, and an inactivated fluorescent protein. The sensor is designed to close around nicotine, and this then activates the fluorescent protein to glow brightly, indicating where the nicotine molecules are located and how many are present.

Scientists can put the biosensors into particular parts of a cell - in this work, they placed them in the endoplasmic reticulum and on cells' surfaces - and watch them light up as nicotine floods in.

By making movies of cells containing biosensors in a lab dish, the team has discovered that nicotine enters into the endoplasmic reticulum within a few seconds of appearing outside a cell. Furthermore, the nicotine levels are more than enough to affect nAChRs during their assembly and to chaperone additional nAChRs on their journey to the cell surface. As a result, the neurons are more sensitive to the nicotine, which enhances the rewarding feelings after a puff on a tobacco cigarette or an e-cigarette. In other words, the more a person smokes, the more quickly and easily the smoker gets a nicotine buzz. This is part of nicotine addiction.

While the movies now focus on isolated neurons in the lab, the scientists want to determine whether nicotine's intracellular movements are similar in the neurons of live mice. Additionally, they are developing biosensors for other drugs, such as opioids and antidepressants, to observe how these compounds interact inside and outside of cells.

Amol V Shivange, Philip M Borden, Anand K Muthusamy, Aaron L Nichols, Kallol Bera, Huan Bao, Ishak Bishara, Janice Jeon, Matthew J Mulcahy, Bruce Cohen, Saidhbhe L O'Riordan, Charlene Kim, Dennis A Dougherty, Edwin R Chapman, Jonathan Marvin, Loren Looger, Henry A Lester.
Determining the pharmacokinetics of nicotinic drugs in the endoplasmic reticulum using biosensors.
The Journal of General Physiology. Feb 2019. doi: 10.1085/jgp.201812201.

Most Popular Now

Merck and Tencent Announce Collaboration…

Merck, a leading science and technology company, signed a strategic collaboration agreement with Tencent, a leading provider of Internet value added services. The collaboration will primarily focus on increasing public...

Merck Granted U.S. Patent for Novel Comb…

Merck, a leading science and technology company, today announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO). The patent relates...

The European Health Catapult Program for…

Through dedicated sessions, a group of international top-level investors, key healthcare leaders and industry stakeholders work closely together challenging 40+ ambitious startups to optimize their business plan and strengthen their...

Applications Now Open for Pioneering Dig…

The Yorkshire & Humber AHSN (Academic Health Science Network), in partnership with mHabitat, announces that applications for the 2019 Propel@YH digital health accelerator programme are now open. Propel@YH has been...

Flagship Axe the Fax Trust Rolls out Hyb…

Leeds Teaching Hospitals NHS Trust (LTHT), the organisation at the forefront of the national Axe the Fax campaign, is implementing an electronic fax solution to tackle its last remaining machines...

First EU Citizens Using ePrescriptions i…

The first EU patients can use digital prescriptions issued by their home doctor when visiting a pharmacy in another EU country: Finnish patients are now able to go to a...

Boehringer Ingelheim (Canada) Ltd. and I…

Boehringer Ingelheim (Canada) Ltd. and IBM Canada announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore the use of blockchain technology...

Final Report: Provision of a Market Stud…

The aim of the study is to examine the telemedicine market in Europe and to understand the factors that determine its development. The analysis maps telemedicine applications and solutions, and...

Open Access Drug Development Tools Featu…

New open access tools for drug development, obesity, and the environmental impacts of medicines are the focus of a new IMI2 Call for proposals launched today. The total budget of...

The NHS Long Term Plan: Cracking the Da …

Opinion Article by Prof. Michael Thick, Chief Medical Officer, Chief Clinical Information Officer, IMS MAXIMS Reading the NHS Long Term Plan this week, I had a definite sense of déjà vu...

Big Data Approach Shown to be Effective …

Researchers at Rensselaer Polytechnic Institute who developed a blood test to help diagnose autism spectrum disorder have now successfully applied their distinctive big data-based approach to evaluating possible treatments. The...

Highland Marketing Advisory Board Respon…

The first meeting of Highland Marketing's newly expanded advisory board discussed the NHS Long Term Plan and what will be needed to make it a success. Structural change, leadership, investment...